CASE NUMBER
1:2018bk10518
1:2018bk10518
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Year
| Mar 12, 2018 | 1 | Petition Chapter 11 Voluntary Petition of Orexigen Therapeutics, Inc.. Fee Amount $1717. Filed by Orexigen Therapeutics, Inc.. (Bibiloni, Jose) (Entered: 03/12/2018) | |
|---|---|---|---|
| Mar 12, 2018 | 2 | Receipt of filing fee for Voluntary Petition (Chapter 11)(18-10518) [misc,volp11a] (1717.00). Receipt Number 8787262, amount $1717.00. (U.S. Treasury) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 3 | Affidavit/Declaration in Support of First Day Motion of Michael A. Narachi in Support of First Day Relief Filed By Orexigen Therapeutics, Inc. (Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 4 | Motion to Approve Debtor In Possession Financing Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 5 | Application to Appoint Claims/Noticing Agent KURTZMAN CARSON CONSULTANTS, LLC Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 6 | Motion to Approve Motion For Entry Of Interim And Final Orders (I) Establishing Notice And Objection Procedures For Transfers Of Equity Securities And (II) Establishing A Record Date For Notice And Sell-Down Procedures For Trading In Claims Against The Debtor's Estate Filed by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 7 | Motion to Maintain Bank Accounts Debtor's Motion For Entry Of Interim And Final Orders (A) Authorizing The Debtor to (I) Continue Its Cash Management Systems, (II) Honor Certain Related Prepetition Obligations, (III) Maintain Existing Business Forms, And (IV) Continue To Perform Intercompany Transactions, (B) Authorizing And Directing The Debtor's Banks To Honor All Related Payment Requests, (C) Granting Interim And Final Waivers Of The Debtor's Compliance With Section 345(b) Of The Bankruptcy Code, (D) Scheduling A Final Hearing, And (E) Granting Related Relief Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 8 | Motion to Continue Customer Programs Debtor's Motion For Interim And Final Orders Pursuant To 11 U.S.C. §§ 105(a), 363, 1107, And 1108 And Fed. R. Bankr. P. 6003 And 6004 Authorizing Debtor To (I) Honor Certain Prepetition Obligations To Customers And To Continue Customer Programs And (II) Pay Medicaid And Other Obligations Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 9 | Motion to Pay Employee Wages Motion Of The Debtor For Interim And Final Orders (I) Authorizing The Debtor To (A) Pay Prepetition Wages, Salaries, And Other Compensation (B) Pay Prepetition Payroll Taxes And Benefits And Continue Benefit Programs In The Ordinary Course, (II) Directing Banks To Honor Checks For Payment Of Prepetition Employee Payment And Program Obligations, And (III) Granting Related Relief Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 10 | Motion to Pay Sales and Use Taxes Debtor's Motion For Entry Of Interim And Final Orders (I) Authorizing The Debtor To Pay Certain Preparation Taxes And Regulatory Fees In The Ordinary Course Of Business And (II) Authorizing Banks And Financial Institutions to Honor And Process Checks And Transfers Related Thereto Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C)(Bibiloni, Jose) (Entered: 03/12/2018) | |
| Mar 12, 2018 | 11 | Motion to Authorize Debtor's Motion For Entry Of Interim And Final Orders (I) Authorizing Debtor To (A) Continue Prepetition Insurance Program; (B) Pay Any Prepetition Premiums And Related Obligations; And (C) Renew Or Enter Into New Insurance Arrangements; And (II) Granting Related Relief Filed by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C) (Bibiloni, Jose) (Entered: 03/12/2018) | |
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
|||
Orexigen Therapeutics, Inc.
3344 N. Torrey Pines Court
Suite 200
La Jolla, CA 92037
SAN DIEGO-CA
Tax ID / EIN: xx-xxx8822
Jose F Bibiloni
Morris, Nichols, Arsht & Tunnell LLP
1201 N. Market Street
P.O. Box 1347
Wilmington, DE 19899
302-351-9472
Fax : 302-425-4668
Email: jbibiloni@mnat.com
U.S. Trustee
Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491
| Date Filed | Name = parent case |
Chapter | Case # |
|---|---|---|---|
| Feb 22, 2023 | CorFunding LLC | 7 | 1:2023bk10239 |
| Feb 13, 2023 | Sorrento Therapeutics, Inc. | 11 | 4:2023bk90085 |
| Dec 22, 2021 | McDowell and Goldman, Inc. | 7 | 3:2021bk04727 |
| Aug 2, 2019 | INTEGRATEDMARKETING.COM | 11 | 3:2019bk04688 |
| Jul 1, 2019 | Dr. James B. DeYarman D.O., Inc. | 7 | 3:2019bk03954 |
| Mar 21, 2019 |
MabVax Therapeutics, Inc.
|
11 | 1:2019bk10604 |
| Mar 21, 2019 | MabVax Therapeutics Holdings, Inc. | 11 | 1:2019bk10603 |
| Sep 29, 2017 | Impeto Medical, Inc. | 7 | 3:17-bk-05927 |
| Mar 2, 2016 | Pediatric Bioscience, Inc. | 7 | 3:16-bk-01185 |
| Feb 2, 2016 | Metis Commercial Finance LLC | 7 | 3:16-bk-00554 |
| May 27, 2014 | PlayMG Corporation | 7 | 3:14-bk-04139 |
| May 9, 2012 | Lawson-Currell Centre, LLC | 11 | 5:12-bk-53559 |
| Apr 23, 2012 | Traversa Therapeutics, Inc. | 7 | 3:12-bk-05752 |
| Dec 28, 2011 | Torrey Pines Securities, Inc. | 7 | 3:11-bk-20665 |
| Sep 13, 2011 | Lava Sport & Fitness, LLC | 7 | 3:11-bk-15226 |
